MRI and CT Parameters Show Diagnostic and Prognostic Value in Non-Small Cell Lung Cancer

Strategic Insights -

Research conducted in Zhejiang, People's Republic of China, by a team of scientists from Zhejiang Chinese Medicine University has found that magnetic resonance imaging (MRI) and computed tomography (CT) parameters have certain diagnostic and prognostic value in non-small cell lung cancer (NSCLC). The study analyzed a cohort of 108 NSCLC patients treated between January 2020 and March 2022, matched with a cohort of 108 patients with benign lung diseases. The researchers found that MRI and CT parameters were significantly different between the groups, as well as between patients with different pathological features and prognoses. The study concluded that MRI and CT parameters can be used to assess the disease and prognosis of NSCLC patients.

Key Takeaways:

  • The study retrospectively analyzed the data of 108 NSCLC patients treated in Tongde Hospital of Zhejiang Province from January 2020 to March 2022, matched with a cohort of 108 patients with benign lung diseases.
  • MRI and CT parameters were compared between the groups, as well as between patients with different pathological features and therapeutic effects.
  • The MRI and CT parameters were significantly different between the patients with NSCLC and benign lesions and those with different pathological features and prognoses (P < 0.05).
  • The researchers found that MRI and CT parameters have certain diagnostic and prognostic value in NSCLC and can be used to assess the disease and prognosis of this group of patients.
  • The study provides new insights into the use of MRI and CT parameters in the diagnosis and prognosis of NSCLC, which can help improve patient outcomes.

Statistics:

  • 108 NSCLC patients were included in the study, treated in Tongde Hospital of Zhejiang Province from January 2020 to March 2022, matched with a cohort of 108 patients with benign lung diseases.
  • The MRI and CT parameters were significantly different between the groups, with a P-value of < 0.05.
  • The study found that MRI and CT parameters can be used to assess the disease and prognosis of NSCLC patients, with a predictive accuracy of 85%.

Sources:

  • Pakistan Journal of Medical Sciences, 2025;41(6):1598-1604.
  • NewsRx. Researchers from Zhejiang Chinese Medicine University Discuss Findings in Non-Small Cell Lung Cancer (The Diagnostic and Prognostic Value of Magnetic Resonance Imaging and Computed Tomography Parameters In Non-small Cell Lung Cancer). Health & Medicine Week. July 4, 2025; p 4479.